Laboratories with experience in conducting independent performance evaluation of in vitro diagnostics (IVDs) are invited to submit an Expression of Interest (EOI) to become a Performance Evaluation
Two laboratories were added to the list of Performance Evaluation Laboratories (PEL) :
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Two virtual CRP Advocacy and Sensitization Workshops were held in partnership with WHO Regional Offices: PAHO-AFRO 8-10 June 2022 and EMRO-SEARO-WPRO 14-16 June 2022.
In partnership with the WHO Country Office in Turkey the PQ Team held an EUL Workshop on the 28 April 2022 with IVD regulators from the national regulatory authority TITCK and IVD manufacturers bas
Continuing its efforts to support prequalification applicants and increase transparency, PQT has started developing Technical Specifications for glucose meters and HbA1c POC IVDs.
Emergency Use Listing (EUL) for candidate in vitro diagnostics (IVDs) to detect SARS-CoV-2 remains ongoing. WHO has expanded the scope of EUL to include SARS-CoV-2 AgRDTs intended for s